News

Researchers have developed an innovative dual-receptor T-cell therapy that promises safer and more effective cancer ...
If you've been hopping between arms for booster shots, a new study suggests that your lymph nodes remember exactly where you ...
The Manila Times is one of the leading national broadsheets in the Philippines. It is also one of the oldest, having been ...
From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...
Zymeworks presents six posters at AACR highlighting advancements in antibody-drug conjugates and T cell engagers, including ZW209's promise in lung cancer. Zymeworks Inc. announced the ...
This study presents a valuable finding on the direct cytotoxic effects of DuoHexaBody-CD37 in diffuse large B-cell lymphoma, mediated via SHP-1 activation and antibody clustering, independent of ...
Based on a proprietary antibody that binds a unique epitope on the costimulatory T cell receptor CD2, we have developed a novel bispecific antibody platform (BiTco) that provides costimulation to T ...
The immediate-past governor of Ebonyi State and serving Minister of Works, Senator David Umahi, has maintained that he had no plan to contest the All Progressives Congress (APC) structure with ...
Produced by ElevenLabs and News Over Audio (Noa) using AI narration. Listen to more stories on the Noa app. Donald Trump’s most frightening power grab was undertaken with an undertone of ...
SAN MATEO, Calif.--(BUSINESS WIRE)--BigHat Biosciences (“BigHat”), a biotechnology company with a machine learning (ML)-guided antibody discovery and development platform, announced a strategic ...
This study reanalyzed previously published scRNA-seq and TCR-seq data to examine the proportion and characteristics of dual-TCR-expressing Treg cells in mice, presenting some useful insights into TCR ...
The main reasons for them not meeting the inclusion criteria were either how close it was after CAR T-cell therapy that they ended up getting the bispecific antibody or their comorbidities. They ...